Targeting IL-β pathway for cancer immunotherapy

被引：4

作者：

Jayaraman, Pushpa ^{[1
]}

Millholland, John ^{[2
]}

O'Brien, Neil ^{[3
]}

Wong, Connie ^{[2
]}

Diwanji, Rohan ^{[1
]}

Wang, Muchun ^{[1
]}

Choi, Elizabeth ^{[1
]}

Linnartz, Ronald ^{[4
]}

Rose, Kristine ^{[4
]}

Rodrik-Outmezguine, Vanessa ^{[4
]}

Pelletier, Marc ^{[5
]}

Savchenko, Alexander ^{[1
]}

Luo, Tong ^{[3
]}

Rezek, Valerie ^{[3
]}

Kitchen, Scott ^{[3
]}

Baum, Jason ^{[2
]}

Sabatos-Peyton, Catherine ^{[1
]}

Martin, Anne-Marie ^{[4
]}

Dranoff, Glenn ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Exploratory Immuno Oncol, Cambridge, MA USA

[2] Novartis, Oncol Precis Med, Cambridge, MA USA

[3] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA

[4] Novartis, Oncol Precis Med, E Hanover, NJ USA

[5] Novartis Inst Biomed Res, Oncol Translat Res, Cambridge, MA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2019年 / 18卷 / 12期

关键词：

D O I：

10.1158/1535-7163.TARG-19-C103

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

C103

引用

页数：3

共 50 条

[21] Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
Thibodeau, Jacques
Bourgeois-Daigneault, Marie-Claude
Lapointe, Rejean
ONCOIMMUNOLOGY, 2012, 1 (06): : 908 - 916
[22] Targeting the IDO1-Kynurenine-AhR pathway for cancer immunotherapy
Pinto, Sheena
Steeneck, Christoph
Albers, Michael
Anderhub, Simon
Birkel, Manfred
Buselic-Woelfel, Larisa
Eisenhardt, Gisela
Kremoser, Claus
Hoffmann, Thomas
Deuschle, Ulrich
CANCER RESEARCH, 2019, 79 (13)
[23] New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
Soler, Maria Florencia
Abaurrea, Andrea
Azcoaga, Peio
Araujo, Angela M.
Caffarel, Maria M.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (11)
[24] From allergy to oncology: Targeting IL-4 to boost cancer immunotherapy
Consonni, Filippo
Corsello, Antonio
Pegoraro, Francesco
ALLERGY, 2024, 79 (10) : 2890 - 2892
[25] Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
Kim, Ji-Hae
Lee, Kun-Joo
Lee, Seung-Woo
BMB REPORTS, 2021, 54 (01) : 21 - 30
[26] Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
Sitkovsky, Michail
Ohta, Akio
JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (02): : 147 - 155
[27] Targeting the LIFR-LCN2 pathway to sensitize liver cancer to immunotherapy
Deng, Yalan
Ma, Li
CANCER RESEARCH, 2024, 84 (06)
[28] 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations
Eric Tran
Paul F Robbins
Steven A Rosenberg
Nature Immunology, 2017, 18 : 255 - 262
[29] Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
Michail Sitkovsky
Akio Ohta
Journal of Molecular Medicine, 2013, 91 : 147 - 155
[30] Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
Dong, Yushan
Chen, Jingyu
Chen, Yuhan
Liu, Songjiang
BIOMEDICINE & PHARMACOTHERAPY, 2023, 167

← 1 2 3 4 5 →